TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.190
+0.050 (4.39%)
At close: Jul 25, 2025, 4:00 PM
1.160
-0.030 (-2.52%)
After-hours: Jul 25, 2025, 7:51 PM EDT
TherapeuticsMD Market Cap
TherapeuticsMD has a market cap or net worth of $13.77 million as of July 25, 2025. Its market cap has decreased by -31.81% in one year.
Market Cap
13.77M
Enterprise Value
15.00M
1-Year Change
-31.81%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since March 27, 2012, TherapeuticsMD's market cap has decreased from $210.70M to $13.77M, a decrease of -93.46%. That is a compound annual growth rate of -18.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 13.80M | 39.39% |
| Dec 31, 2024 | 9.90M | -58.40% |
| Dec 29, 2023 | 23.80M | -55.01% |
| Dec 30, 2022 | 52.90M | -64.99% |
| Dec 31, 2021 | 151.10M | -54.23% |
| Dec 31, 2020 | 330.10M | -49.70% |
| Dec 31, 2019 | 656.20M | -27.60% |
| Dec 31, 2018 | 906.30M | -30.67% |
| Dec 29, 2017 | 1.31B | 15.24% |
| Dec 30, 2016 | 1.13B | -38.50% |
| Dec 31, 2015 | 1.84B | 165.63% |
| Dec 31, 2014 | 694.30M | -8.08% |
| Dec 31, 2013 | 755.30M | 144.20% |
| Dec 31, 2012 | 309.30M | 46.80% |
| Mar 27, 2012 | 210.70M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.19B |
| Johnson & Johnson | 406.87B |
| AbbVie | 336.59B |
| Novo Nordisk | 309.02B |
| UnitedHealth Group | 265.35B |
| Novartis AG | 227.08B |
| AstraZeneca | 224.54B |
| Abbott Laboratories | 218.92B |